Clinigen logo

CLIN - Clinigen Share Price

474.8p -18.2  -3.7%

Last Trade - 03/04/20

Sector
Healthcare
Size
Mid Cap
Market Cap £654.9m
Enterprise Value £977.2m
Revenue £491.7m
Position in Universe 417th / 1834
Bullish
Bearish
Unlock CLIN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CLIN Revenue Unlock CLIN Revenue

Net Income

CLIN Net Income Unlock CLIN Revenue

Normalised EPS

CLIN Normalised EPS Unlock CLIN Revenue

PE Ratio Range

CLIN PE Ratio Range Unlock CLIN Revenue

Dividend Yield Range

CLIN Dividend Yield Range Unlock CLIN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CLIN EPS Forecasts Unlock CLIN Revenue
Profile Summary

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated December 12, 2008
Public Since September 25, 2012
No. of Shareholders: n/a
No. of Employees: 130
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 132,849,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CLIN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CLIN
Upcoming Events for CLIN
Similar to CLIN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.